Cargando…
Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients
PURPOSE: General paresis is a common type of neurosyphilis featuring progressive cognitive deterioration. The lack of a golden standard of diagnosis and its nonspecific clinical manifestations resulted in a high rate of misdiagnoses. This study aims to investigate the clinical, laboratory and radiol...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624117/ https://www.ncbi.nlm.nih.gov/pubmed/37928605 http://dx.doi.org/10.2147/IDR.S421672 |
_version_ | 1785130858841112576 |
---|---|
author | Liu, Mingjuan Tong, Meiyi Zhou, Jia Lan, Yining Wu, Mengyin Zhang, Hanlin Leng, Ling Zheng, Heyi Li, Yanfeng Li, Mingli Li, Jun |
author_facet | Liu, Mingjuan Tong, Meiyi Zhou, Jia Lan, Yining Wu, Mengyin Zhang, Hanlin Leng, Ling Zheng, Heyi Li, Yanfeng Li, Mingli Li, Jun |
author_sort | Liu, Mingjuan |
collection | PubMed |
description | PURPOSE: General paresis is a common type of neurosyphilis featuring progressive cognitive deterioration. The lack of a golden standard of diagnosis and its nonspecific clinical manifestations resulted in a high rate of misdiagnoses. This study aims to investigate the clinical, laboratory and radiological presentations of general paresis and enrich its knowledge for timely diagnoses. PATIENTS AND METHODS: The study collected hospitalized patients admitted for general paresis from September 2002 to November 2022. Their socio-demographical and medical status, clinical presentations, cognitive assessments, laboratory and radiographical manifestations and treatment information were collected retrospectively. RESULTS: A total of 20 males and 5 females were included. Patients’ ages ranged from 30 to 66 years (average 50.3 years). The average and median time for diagnosing general paresis was 14.1 months and 10.0 months respectively. The most frequent initial symptom is memory deterioration (68.0%). Impaired calculative ability and memory deterioration were the most frequent cognitive anomalies, as found in 50% and 45.4% of subjects during examination. The mean and median scores of MoCA was 16.7 and 17 respectively. Serological tests revealed positive TPPA for all patients and a median RPR titer at 1:64 positive. All CSF samples with TPPA and FTA-ABS results reported positivity. The MRI manifestations of general paresis include patchy or speckled hyperintensities (70.8%) and cerebral atrophy (45.8%). The most common lesioned sites in MRI were the ventricular and paraventricular area (50.0%) and temporal lobes (45.8%). For treatment, penicillin-based anti-syphilitic plans were adopted in 17 patients (68.0%). CONCLUSION: The clinical features and radiological alternations of general paresis patients often exhibited diverse and nonspecific alternations. However, some specific clinical manifestations and auxiliary examinations can provide meaningful clues for the identification and differential diagnosis of this disease. |
format | Online Article Text |
id | pubmed-10624117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106241172023-11-04 Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients Liu, Mingjuan Tong, Meiyi Zhou, Jia Lan, Yining Wu, Mengyin Zhang, Hanlin Leng, Ling Zheng, Heyi Li, Yanfeng Li, Mingli Li, Jun Infect Drug Resist Original Research PURPOSE: General paresis is a common type of neurosyphilis featuring progressive cognitive deterioration. The lack of a golden standard of diagnosis and its nonspecific clinical manifestations resulted in a high rate of misdiagnoses. This study aims to investigate the clinical, laboratory and radiological presentations of general paresis and enrich its knowledge for timely diagnoses. PATIENTS AND METHODS: The study collected hospitalized patients admitted for general paresis from September 2002 to November 2022. Their socio-demographical and medical status, clinical presentations, cognitive assessments, laboratory and radiographical manifestations and treatment information were collected retrospectively. RESULTS: A total of 20 males and 5 females were included. Patients’ ages ranged from 30 to 66 years (average 50.3 years). The average and median time for diagnosing general paresis was 14.1 months and 10.0 months respectively. The most frequent initial symptom is memory deterioration (68.0%). Impaired calculative ability and memory deterioration were the most frequent cognitive anomalies, as found in 50% and 45.4% of subjects during examination. The mean and median scores of MoCA was 16.7 and 17 respectively. Serological tests revealed positive TPPA for all patients and a median RPR titer at 1:64 positive. All CSF samples with TPPA and FTA-ABS results reported positivity. The MRI manifestations of general paresis include patchy or speckled hyperintensities (70.8%) and cerebral atrophy (45.8%). The most common lesioned sites in MRI were the ventricular and paraventricular area (50.0%) and temporal lobes (45.8%). For treatment, penicillin-based anti-syphilitic plans were adopted in 17 patients (68.0%). CONCLUSION: The clinical features and radiological alternations of general paresis patients often exhibited diverse and nonspecific alternations. However, some specific clinical manifestations and auxiliary examinations can provide meaningful clues for the identification and differential diagnosis of this disease. Dove 2023-10-30 /pmc/articles/PMC10624117/ /pubmed/37928605 http://dx.doi.org/10.2147/IDR.S421672 Text en © 2023 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Liu, Mingjuan Tong, Meiyi Zhou, Jia Lan, Yining Wu, Mengyin Zhang, Hanlin Leng, Ling Zheng, Heyi Li, Yanfeng Li, Mingli Li, Jun Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients |
title | Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients |
title_full | Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients |
title_fullStr | Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients |
title_full_unstemmed | Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients |
title_short | Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients |
title_sort | clinical and laboratory characteristics, neuroimaging alternations and treatment response of 25 hiv-negative general paresis patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624117/ https://www.ncbi.nlm.nih.gov/pubmed/37928605 http://dx.doi.org/10.2147/IDR.S421672 |
work_keys_str_mv | AT liumingjuan clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT tongmeiyi clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT zhoujia clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT lanyining clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT wumengyin clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT zhanghanlin clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT lengling clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT zhengheyi clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT liyanfeng clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT limingli clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients AT lijun clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients |